Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Adina Bar

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Human Vaccines & Immunotherapeutics|October 30, 2020
Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreakRavit Bassal, Victoria Indenbaum, Rakefet Pando, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 3, 2022
Population differences in antibody response to SARS-CoV-2 infection and BNT162b2 vaccinationGuy Shapira, Ramzia Abu Hamad, Chen Weiner, et al.
The Pediatric Infectious Disease Journal|April 7, 2017
Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Pediatric Solid-organ Transplant Recipients: A Prospective Pharmacokinetic StudyOrit Peled, Matitiahu Berkovitch, Eran Rom, et al.
Vaccines|July 27, 2022
The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015Ravit Bassal, Tamy Shohat, Tal Levin, et al.
The New England Journal of Medicine|July 28, 2021
Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersMoriah Bergwerk, Tal Gonen, Yaniv Lustig, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 12, 2021
The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021Neta Zuckerman, Ital Nemet, Limor Kliker, et al.
Elife|January 27, 2023
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional studyAvner Ehrlich, Konstantinos Ioannidis, Makram Nasar, et al.
Eclinicalmedicine|November 25, 2020
Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulationKfir Oved, Liraz Olmer, Yonat Shemer-Avni, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Human Vaccines & Immunotherapeutics|October 30, 2020
Seropositivity of measles antibodies in the Israeli population prior to the nationwide 2018 - 2019 outbreakRavit Bassal, Victoria Indenbaum, Rakefet Pando, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|March 3, 2022
Population differences in antibody response to SARS-CoV-2 infection and BNT162b2 vaccinationGuy Shapira, Ramzia Abu Hamad, Chen Weiner, et al.
The Pediatric Infectious Disease Journal|April 7, 2017
Valganciclovir Dosing for Cytomegalovirus Prophylaxis in Pediatric Solid-organ Transplant Recipients: A Prospective Pharmacokinetic StudyOrit Peled, Matitiahu Berkovitch, Eran Rom, et al.
Vaccines|July 27, 2022
The Concordance between Mumps and Rubella Sero-Positivity among the Israeli Population in 2015Ravit Bassal, Tamy Shohat, Tal Levin, et al.
The New England Journal of Medicine|July 28, 2021
Covid-19 Breakthrough Infections in Vaccinated Health Care WorkersMoriah Bergwerk, Tal Gonen, Yaniv Lustig, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 12, 2021
The SARS-CoV-2 Lambda variant and its neutralisation efficiency following vaccination with Comirnaty, Israel, April to June 2021Neta Zuckerman, Ital Nemet, Limor Kliker, et al.
Elife|January 27, 2023
Efficacy and safety of metabolic interventions for the treatment of severe COVID-19: in vitro, observational, and non-randomized open-label interventional studyAvner Ehrlich, Konstantinos Ioannidis, Makram Nasar, et al.
Eclinicalmedicine|November 25, 2020
Multi-center nationwide comparison of seven serology assays reveals a SARS-CoV-2 non-responding seronegative subpopulationKfir Oved, Liraz Olmer, Yonat Shemer-Avni, et al.
Pageof 4